Skip to main content
SpringerLink
Log in

New benefits of statin treatment

  • Clinical Trials Report
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cannon CP, Braunwald E, McCabe CH, et al.: Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004, 350:1495–1504.

    Article  PubMed  CAS  Google Scholar 

  2. Nissen SE, Tuzcu EM, Schoenhagen P, et al.: Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004, 291:1071–1080.

    Article  PubMed  CAS  Google Scholar 

  3. Sacks FM: High-intensity statin treatment for coronary heart disease. JAMA 2004, 291:1132–1134.

    Article  PubMed  CAS  Google Scholar 

  4. Topol EJ: Intensive statin therapy-a sea change in cardiovascular prevention. N Engl J Med 2004, 350:1562–1564.

    Article  PubMed  CAS  Google Scholar 

  5. Liao JK: Isoprenoids as mediators of the biological effects of statins. J Clin Invest 2002, 110:285–288.

    Article  PubMed  CAS  Google Scholar 

  6. Albert MA, Danielson E, Rifai N, Ridker PM: Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/ CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 2001, 286:64–70.

    Article  PubMed  CAS  Google Scholar 

  7. Ridker PM, Rifai N, Rose L, et al.: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002, 347:1557–1565.

    Article  PubMed  CAS  Google Scholar 

  8. Ridker PM: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003, 107:363–369.

    Article  PubMed  Google Scholar 

  9. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836–843.

    Article  PubMed  CAS  Google Scholar 

  10. Ridker PM, Cannon CP, Morrow D, et al.: C-reactive protein levels and outcomes after statin therapy. N Engl J Med 2005, 352:20–28.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Boden Guenther MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boden, G. New benefits of statin treatment. Curr Diab Rep 5, 165–166 (2005). https://doi.org/10.1007/s11892-005-0003-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-005-0003-6

Keywords

Search

Navigation